Woodline Partners LP Kiniksa Pharmaceuticals, Ltd. Transaction History

Woodline Partners LP

  • $13.5 Billion
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
BUY
$10.44 - $16.48 $3.03 Million - $4.78 Million
290,001 New
290,001 $4.08 Million
Q2 2022

Aug 15, 2022
BUY
$7.6 - $11.41 $2.53 Million - $3.8 Million
332,893 New
332,893 $3.23 Million
Q4 2021

Feb 14, 2022
SELL
$10.39 - $15.15 $2.43 Million - $3.55 Million
-234,357 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$11.39 - $16.23 $2.67 Million - $3.8 Million
234,357 New
234,357 $2.67 Million

Others Institutions Holding KNSA

# of Institutions
8
Shares Held
1.95M
Call Options Held
0
Put Options Held
0
View Full List

About Kiniksa Pharmaceuticals, Ltd.

KNSA Quotes by TradingView
  • Ticker KNSA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,470,400
  • Market Cap $680M
  • Description
  • Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...
More about KNSA
Track This Portfolio

Track Woodline Partners LP Portfolio

Follow Woodline Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Woodline Partners LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email